FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 56 filers reported holding FENNEC PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $4,000 | -84.0% | 642 | -81.1% | 0.00% | – |
Q4 2020 | $25,000 | +257.1% | 3,395 | +237.1% | 0.00% | – |
Q3 2020 | $7,000 | -50.0% | 1,007 | -42.6% | 0.00% | – |
Q2 2020 | $14,000 | – | 1,755 | +9650.0% | 0.00% | – |
Q1 2020 | $0 | – | 18 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 18 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 18 | -81.4% | 0.00% | – |
Q2 2019 | $0 | – | 97 | +223.3% | 0.00% | – |
Q1 2019 | $0 | -100.0% | 30 | -83.7% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 184 | +87.8% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 98 | -1.0% | 0.00% | – |
Q2 2018 | $1,000 | – | 99 | +450.0% | 0.00% | – |
Q1 2018 | $0 | – | 18 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 18 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 18 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Solas Capital Management, LLC | 867,857 | $6,327,000 | 4.44% |
Sonic Fund II, L.P. | 2,433,230 | $17,738,000 | 1.31% |
DG Capital Management, LLC | 588,773 | $4,292,000 | 0.93% |
Southpoint Capital Advisors LP | 4,077,214 | $29,723,000 | 0.52% |
HARBERT FUND ADVISORS, INC. | 120,851 | $881,000 | 0.49% |
683 Capital Management, LLC | 1,110,000 | $8,091,000 | 0.28% |
Avoro Capital Advisors LLC | 1,670,000 | $12,174,000 | 0.21% |
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $292,000 | 0.16% |
Tibra Equities Europe Ltd | 46,300 | $338,000 | 0.10% |
GSA CAPITAL PARTNERS LLP | 68,724 | $501,000 | 0.06% |